Literature DB >> 9560310

Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1.

A P Mould1, A N Garratt, W Puzon-McLaughlin, Y Takada, M J Humphries.   

Abstract

The molecular mechanisms that regulate integrin-ligand binding are unknown; however, bivalent cations are essential for integrin activity. According to recent models of integrin tertiary structure, sites involved in ligand recognition are located on the upper face of the seven-bladed beta-propeller formed by the N-terminal repeats of the alpha subunit and on the von Willebrand factor A-domain-like region of the beta subunit. The epitopes of function-altering monoclonal antibodies (mAbs) cluster in these regions of the alpha and beta subunits; hence these mAbs can be used as probes to detect changes in the exposure or shape of the ligand-binding sites. Bivalent cations were found to alter the apparent affinity of binding of the inhibitory anti-alpha5 mAbs JBS5 and 16, the inhibitory anti-beta1 mAb 13, and the stimulatory anti-beta1 mAb 12G10 to alpha5 beta1. Analysis of the binding of these mAbs to alpha5beta1 over a range of Mn2+, Mg2+ or Ca2+ concentrations demonstrated that there was a concordance between the ability of cations to elicit conformational changes and the ligand-binding potential of alpha5 beta1. Competitive ELISA experiments provided evidence that the domains of the alpha5 and beta1 subunits recognized by mAbs JBS5/16 and 13/12G10 are spatially close, and that the distance between these two domains is increased when alpha5 beta1 is occupied by bivalent cations. Taken together, our findings suggest that bivalent cations induce a conformational relaxation in the integrin that results in exposure of ligand-binding sites, and that these sites lie near an interface between the alpha subunit beta-propeller and the beta subunit putative A-domain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560310      PMCID: PMC1219423          DOI: 10.1042/bj3310821

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Regulation of conformation and ligand binding function of integrin alpha5beta1 by the beta1 cytoplasmic domain.

Authors:  W Puzon-McLaughlin; T A Yednock; Y Takada
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

2.  The 2.0 A crystal structure of a heterotrimeric G protein.

Authors:  D G Lambright; J Sondek; A Bohm; N P Skiba; H E Hamm; P B Sigler
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

3.  Regulation of integrin alpha 5 beta 1 function by anti-integrin antibodies and divalent cations.

Authors:  A P Mould; A N Garratt; J A Askari; S K Akiyama; M J Humphries
Journal:  Biochem Soc Trans       Date:  1995-08       Impact factor: 5.407

4.  Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18).

Authors:  J O Lee; P Rieu; M A Arnaout; R Liddington
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

5.  Monoclonal antibody 9EG7 defines a novel beta 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium.

Authors:  G Bazzoni; D T Shih; C A Buck; M E Hemler
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

6.  Regulation of integrin alpha 5 beta 1-fibronectin interactions by divalent cations. Evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+.

Authors:  A P Mould; S K Akiyama; M J Humphries
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

7.  Control of beta1 integrin function. Localization of stimulatory epitopes.

Authors:  J A Wilkins; A Li; H Ni; D G Stupack; C Shen
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

8.  Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29)

Authors:  T Kamata; W Puzon; Y Takada
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

9.  Molecular mapping of functional antibody binding sites of alpha 4 integrin.

Authors:  S G Schiffer; M E Hemler; R R Lobb; R Tizard; L Osborn
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

10.  Critical amino acid residues for ligand binding are clustered in a predicted beta-turn of the third N-terminal repeat in the integrin alpha 4 and alpha 5 subunits.

Authors:  A Irie; T Kamata; W Puzon-McLaughlin; Y Takada
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

View more
  27 in total

1.  Fine mapping of inhibitory anti-alpha5 monoclonal antibody epitopes that differentially affect integrin-ligand binding.

Authors:  L Burrows; K Clark; A P Mould; M J Humphries
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

3.  Divalent cations regulate the folding and activation status of integrins during their intracellular trafficking.

Authors:  Shweta Tiwari; Janet A Askari; Martin J Humphries; Neil J Bulleid
Journal:  J Cell Sci       Date:  2011-04-21       Impact factor: 5.285

4.  A peptide domain of bovine milk lactoferrin inhibits the interaction between streptococcal surface protein antigen and a salivary agglutinin peptide domain.

Authors:  Takahiko Oho; Floris J Bikker; Arie V Nieuw Amerongen; Jasper Groenink
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Novel activating and inactivating mutations in the integrin beta1 subunit A domain.

Authors:  Stephanie J Barton; Mark A Travis; Janet A Askari; Patrick A Buckley; Susan E Craig; Martin J Humphries; A Paul Mould
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

6.  Clustering of syndecan-4 and integrin beta1 by laminin alpha 3 chain-derived peptide promotes keratinocyte migration.

Authors:  Eri Araki; Yutaka Momota; Takeshi Togo; Miki Tanioka; Kentaro Hozumi; Motoyoshi Nomizu; Yoshiki Miyachi; Atsushi Utani
Journal:  Mol Biol Cell       Date:  2009-04-29       Impact factor: 4.138

7.  Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function.

Authors:  Christi Parham; Lisa Auckland; Jessica Rachwal; Douglas Clarke; Gregory Bix
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  Therapeutic ultrasound bypasses canonical syndecan-4 signaling to activate rac1.

Authors:  Claire M Mahoney; Mark R Morgan; Andrew Harrison; Martin J Humphries; Mark D Bass
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

9.  Integrin expression regulates neuroblastoma attachment and migration.

Authors:  Amy Meyer; Cynthia M van Golen; Bhumsoo Kim; Kenneth L van Golen; Eva L Feldman
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

10.  A D-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization.

Authors:  Donna M Veine; Hongren Yao; Daniel R Stafford; Kevin S Fay; Donna L Livant
Journal:  Clin Exp Metastasis       Date:  2014-01-25       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.